People: JCR Pharmaceuticals Co Ltd (4552.T)

4552.T on Tokyo Stock Exchange

20 Sep 2019
Change (% chg)

¥-10 (-0.12%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Yoda, Toshihide 

Mr. Toshihide Yoda was named Independent Director in JCR Pharmaceuticals Co., Ltd. effective June 2018. He is also serving as Managing Director, Chief Director of Business Development and Director of Business Development in Business Development Unit in Medipal Holdings Corporation, as well as Director in SPLine Corporation, Medie Co., Ltd., MEDICEO CORPORATION and JCR USA, Inc. He used to work for other five companies, including Mizuho Investors Securities Co., Ltd., UBS Securities Japan Co., Ltd. and Lehman Brothers Securities Japan Co., Ltd.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --